Bulletin
Investor Alert

Illumina Inc.

NAS: ILMN

GO

Set Alerts

Market Index

Overview Profile Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders
/marketstate/country/us
Illumina Inc.

After Hours

 --Quotes are delayed by 20 min

Jan 27, 2023, 7:59 p.m.

ILMN
/zigman2/quotes/203509482/composite

$

213.99

Change

-0.04 -0.02%

Volume

Volume 36,293

Quotes are delayed by 20 min

/zigman2/quotes/203509482/composite

Previous close

$ 212.78

$ 214.03

Change

+1.25 +0.59%

Day low

Day high

$207.83

$215.09

Open

52 week low

52 week high

$173.45

$371.16

Open

Company Description

Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through the Core Illumina segment, which serves customers in the research, clinical and applied markets fields,...

Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through the Core Illumina segment, which serves customers in the research, clinical and applied markets fields, and enables the adoption of a variety of genomic solutions. The firm's products include instruments, kits and reagents, selection tools, and software and analysis. Its services include sequencing and microarray services, proactive instrument monitoring, and instrument services, training, and consulting. The company was founded by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock, and Mark S. Chee in April 1998 and is headquartered in San Diego, CA.

Valuation

P/E Current

42.17

P/E Ratio (without extraordinary items)

75.39

Price to Sales Ratio

12.69

Price to Book Ratio

5.56

Price to Cash Flow Ratio

102.95

Enterprise Value to EBITDA

64.56

Enterprise Value to Sales

7.38

Efficiency

Total Asset Turnover

0.40

Liquidity

Current Ratio

2.48

Quick Ratio

2.09

Cash Ratio

1.23

Profitability

Gross Margin

69.69

Operating Margin

6.32

Pretax Margin

19.53

Net Margin

16.84

Return on Assets

6.68

Return on Equity

9.87

Return on Total Capital

2.88

Capital Structure

Total Debt to Total Assets

16.69

Officers and Executives

Name Age Officer Since Title
Mr. Francis A. deSouza 48 2013 President
Mr. Kevin Pegels - 2021 Chief-Global Operations
Dr. Joydeep Goswami 48 2019 SVP-Corporate Development & Strategic Planning
Dr. Alex Aravanis - 2020 Chief Technology Officer & Senior Vice President
Ms. Carissa Rollins - 2022 Chief Information Officer

Insider Actions

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
01/09/2023 Aimee Hoyt
SVP, Chief People Officer 		871   Disposition at $205.57 per share. 179,051
01/06/2023 Susan H. Tousi
SVP, Chief Commercial Officer 		500   Disposition at $204.58 per share. 102,290
12/06/2022 Susan H. Tousi
SVP, Chief Commercial Officer 		500   Disposition at $212.63 per share. 106,315
11/08/2022 Alex Aravanis
SVP, Chief Technology Officer 		361   Disposition at $218 per share. 78,698
11/07/2022 Susan H. Tousi
SVP, Chief Commercial Officer 		500   Disposition at $223.65 per share. 111,825
11/07/2022 Aimee Hoyt
SVP, Chief People Officer 		1,045   Disposition at $223.65 per share. 233,714
11/07/2022 Aimee Hoyt
SVP, Chief People Officer 		1,294   Disposition at $223.65 per share. 289,403
11/05/2022 Francis A. deSouza
President and CEO; Director 		2,591   Derivative/Non-derivative trans. at $217.19 per share. 562,739
11/05/2022 Susan H. Tousi
SVP, Chief Commercial Officer 		721   Derivative/Non-derivative trans. at $217.19 per share. 156,593
11/05/2022 Joydeep Goswami
SVP Corp Business Development 		638   Derivative/Non-derivative trans. at $217.19 per share. 138,567
11/05/2022 Charles E. Dadswell
SVP & General Counsel 		853   Derivative/Non-derivative trans. at $217.19 per share. 185,263
11/05/2022 Kevin Pegels
Chief of Global Operations 		472   Derivative/Non-derivative trans. at $217.19 per share. 102,513
11/05/2022 Scott Ericksen
VP, Chief Accounting Officer 		213   Derivative/Non-derivative trans. at $217.19 per share. 46,261
11/05/2022 Phillip G. Febbo
SVP Chief Medical Officer 		821   Derivative/Non-derivative trans. at $217.19 per share. 178,312
11/05/2022 Kathryne Reeves
SVP, Chief Marketing Officer 		212   Derivative/Non-derivative trans. at $217.19 per share. 46,044
11/05/2022 Aimee Hoyt
SVP, Chief People Officer 		640   Derivative/Non-derivative trans. at $217.19 per share. 139,001
11/05/2022 Alex Aravanis
SVP, Chief Technology Officer 		191   Derivative/Non-derivative trans. at $217.19 per share. 41,483
10/06/2022 Susan H. Tousi
SVP, Chief Commercial Officer 		500   Disposition at $216.59 per share. 108,295
10/05/2022 Joydeep Goswami
SVP Corp Business Development 		165   Derivative/Non-derivative trans. at $218.52 per share. 36,055
10/05/2022 Kathryne Reeves
SVP, Chief Marketing Officer 		73   Derivative/Non-derivative trans. at $218.52 per share. 15,951
07/07/2022 Alex Aravanis
SVP, Chief Technology Officer 		539   Disposition at $200 per share. 107,800
07/05/2022 Alex Aravanis
SVP, Chief Technology Officer 		285   Derivative/Non-derivative trans. at $193.02 per share. 55,010
/news/latest/company/us/ilmn

MarketWatch News on ILMN

  1. Illumina Inc. stock outperforms competitors on strong trading day

    5:01 p.m. Jan. 27, 2023

    - MarketWatch Automation

  2. Illumina Inc. stock rises Thursday, still underperforms market

    5:01 p.m. Jan. 26, 2023

    - MarketWatch Automation

  3. Illumina Inc. stock underperforms Wednesday when compared to competitors

    5:01 p.m. Jan. 25, 2023

    - MarketWatch Automation

  4. Illumina Inc. stock falls Tuesday, underperforms market

    5:01 p.m. Jan. 24, 2023

    - MarketWatch Automation

  5. Illumina Inc. stock rises Monday, outperforms market

    5:01 p.m. Jan. 23, 2023

    - MarketWatch Automation

  6. Illumina Inc. stock falls Thursday, underperforms market

    5:01 p.m. Jan. 19, 2023

    - MarketWatch Automation

  7. Illumina Inc. stock falls Wednesday, still outperforms market

    5:01 p.m. Jan. 18, 2023

    - MarketWatch Automation

  8. Illumina Inc. stock outperforms competitors on strong trading day

    5:01 p.m. Jan. 17, 2023

    - MarketWatch Automation

  9. Why Chip Maker Nvidia Was at a Healthcare Conference

    2:14 p.m. Jan. 14, 2023

    - Barron's Online

  10. Illumina Inc. stock rises Friday, outperforms market

    5:01 p.m. Jan. 13, 2023

    - MarketWatch Automation

  11. Illumina Inc. stock underperforms Thursday when compared to competitors

    5:01 p.m. Jan. 12, 2023

    - MarketWatch Automation

  12. Illumina Inc. stock outperforms market on strong trading day

    5:01 p.m. Jan. 11, 2023

    - MarketWatch Automation

  13. Illumina Inc. stock underperforms Tuesday when compared to competitors

    5:01 p.m. Jan. 10, 2023

    - MarketWatch Automation

  15. Why Illumina Has Grown Cautious and What It Means for the Stock

    12:36 p.m. Jan. 10, 2023

    - Barron's Online

  17. Illumina Inc. stock rises Monday, outperforms market

    5:01 p.m. Jan. 9, 2023

    - MarketWatch Automation

  18. Why a Long-Term Investor Is Sticking With Tesla and Cloud Shares

    6:19 p.m. Jan. 8, 2023

    - Barron's Online

  19. Illumina Inc. stock rises Friday, still underperforms market

    5:02 p.m. Jan. 6, 2023

    - MarketWatch Automation

  20. Illumina Inc. stock underperforms Thursday when compared to competitors

    5:01 p.m. Jan. 5, 2023

    - MarketWatch Automation

  21. Loading more headlines...
/news/nonmarketwatch/company/us/ilmn

Other News on ILMN

  1. Baillie Gifford Slashes Meta, Boosts Nvidia

    5:11 p.m. Jan. 25, 2023

    - GuruFocus.com

  2. Top 5 4th Quarter Trades of Amazon com Inc

    6:00 p.m. Jan. 18, 2023

    - GuruFocus.com

  3. STONNINGTON GROUP, LLC Buys 2, Sells 3 in 4th Quarter

    6:00 p.m. Jan. 11, 2023

    - GuruFocus.com

  4. Aurora Investment Managers, LLC. Buys 3, Sells 2 in 4th Quarter

    4:00 p.m. Jan. 11, 2023

    - GuruFocus.com

  6. Illumina: A Growth Stock in Waiting

    10:13 a.m. Jan. 4, 2023

    - GuruFocus.com

  7. Guardant Health Drops 30% as Cancer Test Disappoints

    5:17 p.m. Dec. 16, 2022

    - GuruFocus.com

  8. Among the Best-Managed Companies of 2022, Some Warning Signs

    9:08 a.m. Dec. 11, 2022

    - Chris Kornelis

  12. Illumina to shed 5% of global headcount

    6:40 a.m. Nov. 15, 2022

    - Seeking Alpha

  13. Alyeska Investment Group, L.P. Buys 4, Sells 1 in 3rd Quarter

    4:00 a.m. Nov. 15, 2022

    - GuruFocus.com

  15. Twist Bioscience: Cash Burn Continues To Be The Issue

    12:17 p.m. Nov. 11, 2022

    - Seeking Alpha

  16. POLEN CAPITAL MANAGEMENT LLC Buys 2, Sells 3 in 3rd Quarter

    1:00 p.m. Nov. 4, 2022

    - GuruFocus.com

  18. Illumina, Inc. (ILMN) Q3 2022 Earnings Call Transcript

    9:59 p.m. Nov. 3, 2022

    - Seeking Alpha

  20. Illumina slips as GRAIL impairment prompts guidance cut

    5:00 p.m. Nov. 3, 2022

    - Seeking Alpha

  21. Loading more headlines...

At a Glance

Illumina, Inc.

5200 Illumina Way

San Diego, California 92122

Phone

1 8582024500

Industry

Biotechnology

Sector

Health Care/Life Sciences

Fiscal Year-end

12/2022

View SEC Filings

Revenue

$4.53B

Net Income

$762.00M

Employees

9,800

Annual Report for ILMN

/news/pressrelease/company/us/ilmn

Press Releases on ILMN

  4. Illumina (ILMN) Trading Report

    11:15 p.m. Jan. 19, 2023

    - Stock Traders Daily

  6. Nasdaq 100 Movers: ZS, CTSH

    10:22 a.m. Jan. 12, 2023

    - MarketNewsVideo.com

  7. S&P 500 Movers: CRL, CTSH

    10:17 a.m. Jan. 12, 2023

    - MarketNewsVideo.com

  9. Tuesday's ETF with Unusual Volume: FBT

    12:14 p.m. Jan. 10, 2023

    - MarketNewsVideo.com

  10. Nasdaq 100 Movers: ILMN, WBD

    11:48 a.m. Jan. 10, 2023

    - MarketNewsVideo.com

  11. S&P 500 Movers: ILMN, WBD

    11:46 a.m. Jan. 10, 2023

    - MarketNewsVideo.com

  12. Illumina (ILMN) Trading Report

    9:25 a.m. Jan. 10, 2023

    - Stock Traders Daily

  15. Nasdaq 100 Movers: ILMN, COST

    11:46 a.m. Jan. 6, 2023

    - MarketNewsVideo.com

  16. How the price action of Illumina (ILMN) is used to our Advantage

    5:54 p.m. Dec. 31, 2022

    - Stock Traders Daily

  17. Trading Illumina ILMN With Integrated Risk Controls

    3:31 a.m. Dec. 22, 2022

    - Stock Traders Daily

  18. Illumina To Webcast Upcoming Investor Conference

    4:05 p.m. Dec. 19, 2022

    - PR Newswire - PRF

  21. Loading more headlines...
Link to MarketWatch's Slice.